I'm LOADING UP On Google Stock! Here's why:
1 extracted signal · 0 resolved · 1 still active
The Patient InvestorIndependent analyst profile- Source published
- 29 Oct 2026, 18:32 UTC
- Recorded by Tahlil Plus
- 29 Oct 2026, 22:22 UTC

AI-generated source summary
The analysis focuses on Google (GOOGL) from a fundamental and valuation perspective. The speaker initiated a short position with a target of $200 and a stop-loss at $290, believing the stock is overvalued. This is based on a P/E ratio of 19, which the speaker considers high given Google's growth prospects. The speaker presents a valuation model projecting EPS growth of 15% annually. Under a base case scenario with a P/E ratio of 20, the target price is $305, implying a 7.06% return. In an optimistic scenario with a P/E of 25, the target rises to $472, with a 27.1% annual return. However, the speaker expresses skepticism about Google's search engine's long-term viability due to AI advancements, and notes that while Google Cloud is performing well, the search engine's revenue growth has stagnated. The speaker also highlights Google's substantial investment portfolio, particularly in AI companies like Anthropic, and its strong balance sheet with significant cash reserves. Despite the bearish sentiment on the search engine's future, the analysis suggests that Google's diversified business model and AI investments provide a potential hedge and future growth opportunities.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
